Ventyx Biosciences Inc [NASDAQ: VTYX] stock went on a downward path that fall over -1.94% on Thursday, amounting to a one-week price increase of more than 31.23%.
Over the last 12 months, VTYX stock rose by 61.19%. The one-year Ventyx Biosciences Inc stock forecast points to a potential upside of 69.12. The average equity rating for VTYX stock is currently 1.44, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $251.72 million, with 71.23 million shares outstanding and 63.19 million shares in the current float. Compared to the average trading volume of 943.78K shares, VTYX stock reached a trading volume of 3829040 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Ventyx Biosciences Inc [VTYX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VTYX shares is $11.43 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VTYX stock is a recommendation set at 1.44. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Ventyx Biosciences Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 12, 2024. The new note on the price target was released on March 12, 2024, representing the official price target for Ventyx Biosciences Inc stock. Previously, the target price had yet another drop from $77 to $8, while Wells Fargo kept a Equal Weight rating on VTYX stock.
The Price to Book ratio for the last quarter was 1.20, with the Price to Cash per share for the same quarter was set at 2.93.
VTYX Stock Performance Analysis:
Ventyx Biosciences Inc [VTYX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 31.23. With this latest performance, VTYX shares gained by 36.82% in over the last four-week period, additionally plugging by 233.02% over the last 6 months – not to mention a rise of 61.19% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VTYX stock in for the last two-week period is set at 73.24, with the RSI for the last a single of trading hit 0.30, and the three-weeks RSI is set at 0.25 for Ventyx Biosciences Inc [VTYX]. The present Moving Average for the last 50 days of trading for this stock 2.68, while it was recorded at 3.25 for the last single week of trading, and 2.04 for the last 200 days.
Ventyx Biosciences Inc (VTYX) Capital Structure & Debt Analysis
According to recent financial data for Ventyx Biosciences Inc. ( VTYX), the Return on Equity (ROE) stands at -48.56%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -44.15%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Ventyx Biosciences Inc’s Return on Invested Capital (ROIC) is -54.46%, showcasing its effectiveness in deploying capital for earnings.
Ventyx Biosciences Inc (VTYX) Efficiency & Liquidity Metrics
Based on Ventyx Biosciences Inc’s (VTYX) latest financial statements, the Debt-to-Equity Ratio is 0.05%, indicating its reliance on debt financing relative to shareholder equity.
Ventyx Biosciences Inc (VTYX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Ventyx Biosciences Inc. (VTYX) effectively leverages its workforce, generating an average of -$1451585.37 per employee. The company’s liquidity position is robust, with a Current Ratio of 19.12% and a Quick Ratio of 19.12%, indicating strong ability to cover short-term liabilities.
VTYX Stock EPS
With the latest financial reports released by the company, Ventyx Biosciences Inc posted -0.5/share EPS, while the average EPS was predicted by analysts to be reported at -0.51/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VTYX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Ventyx Biosciences Inc go to 0.85%.
Ventyx Biosciences Inc [VTYX] Institutonal Ownership Details
There are presently around $68.72%, or 71.66%% of VTYX stock, in the hands of institutional investors. The top three institutional holders of VTYX stocks are: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with ownership of 5.83 million shares, which is approximately 8.2625%. CITADEL ADVISORS LLC, holding 5.76 million shares of the stock with an approximate value of $$13.3 million in VTYX stocks shares; and CITADEL ADVISORS LLC, currently with $$12.12 million in VTYX stock with ownership which is approximately 7.4377%.
